• EN

Please note that the information on this page is based on the EMCDDA Annual report 2011: the state of the drugs problem in Europe. Most statistical data relate to the year 2009 (or the last year available).

Annual report 2011: the state of the drugs problem in Europe
New drugs and emerging trends

Published: 15 November 2011


The provision of timely and objective information on new drugs and emerging trends is of growing importance, given the increasingly dynamic and fast-moving nature of the European drugs problem. The new drugs market is distinguished by the speed at which suppliers respond to the imposition of control measures by offering new alternatives to restricted products. A range of information sources and leading-edge indicators, including Internet monitoring and wastewater analysis, can assist in providing a better picture of emerging drug trends in Europe. This chapter details the new psychoactive substances detected through the early-warning system, and follows up on the risk assessment of mephedrone. The 'legal highs' phenomenon is examined, along with a number of national responses to the open sale of new substances.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Friday, 28 October 2011